## WDAY: Workday, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.74 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($209.95)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. |Workday Q3 Earnings Beat Estimates on Solid Revenue Growth**
- Source: TradingView | 20251208T042252 | Bullish | Relevance: 99%
-  |Workday (WDAY) reported strong third-quarter fiscal 2026 results, surpassing Zacks Consensus Estimates for both earnings and revenue. This growth was fueled by solid customer acquisition across various sectors and the company's focus on innovation, AI integration, and international expansion. Workday also provided optimistic guidance for the fourth quarter and full fiscal year 2026.

**2. Enterprises Unify, Accelerate Business Planning with AI-powered Software Platforms, ISG Says**
- Source: Business Wire | 20251209T150932 | Somewhat-Bullish | Relevance: 73%
-  According to new research from Information Services Group (ISG), companies are increasingly using dedicated AI-powered business planning software to integrate planning activities and align them with enterprise strategy. This approach helps companies anticipate change, manage resources, and pursue growth by overcoming the limitations of siloed planning. The ISG Buyers Guideâ„¢ for Business Planning highlights how these platforms, with emerging AI features, refine forecasting, planning, analysis, and decision-making cycles, making them faster and more agile.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 11)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Rosenblatt | $235 | $0 | 0% |
| 2025-11-26 | Citigroup | $247 | $261 | -5% |
| 2025-11-26 | DA Davidson | $250 | $260 | -4% |
| 2025-11-26 | JP Morgan | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Rosenblatt | init | Neutral |
| 2025-11-26 | Citigroup | main | Neutral |
| 2025-11-26 | DA Davidson | main | Neutral |
| 2025-11-26 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 19 ($16.71M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 13.9% (+3.2%)
- Blackrock Inc.: 12.5% (+4.6%)
- State Street Corpora: 6.2% (+0.8%)
- Eagle Capital Manage: 4.9% (+33.3%)
- Hotchkis & Wiley Cap: 3.7% (+47.5%)

### Key Risks

1. Heavy insider selling: $17M sold (19 transactions in 90 days).
2. Long-term trend broken: trading 6.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.74 indicates undervaluation relative to growth. Analyst sentiment negative (11 target cuts vs 1 raises). Insider selling cluster ($16.7M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $59.5B |
| Beta | 1.15 |
| 52W Range | $205.33 - $283.68 |
| Short Interest | 4.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.74 |
| Forward P/E | 20.8 |
| Current P/E | 24.5 |
| YoY Growth | 17.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.7% to -1.9% (+2.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.7%) - potential reversal signal. Underperforming sector by 3.3pp, stock-specific weakness. Below SMA200 (0.94x), long-term trend not supportive. MACD histogram positive (0.76), confirming momentum. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.95% (CS: 40) | Neutral |
| RSI_14 | 49.0 | Neutral |
| MACD Histogram | 0.76 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 0.970x | Below |
| vs SMA200 | 0.940x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $222.75
- **Stop Loss:** $209.95 (5.7% risk)
- **Target:** $248.35 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $20,715.75
- **Portfolio %:** 20.72%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-02-24 (Est: $2.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.17 | $2.32 | +6.7% |
| 2025Q3 | $2.12 | $2.21 | +4.4% |
| 2025Q2 | $2.01 | $2.23 | +11.0% |
| 2025Q1 | $1.78 | $1.92 | +8.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*